Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)

Participants of the study ESSE-RF-2 and co-authors: Moscow: Konstantinov V. V., Pokrovskaya M.S., Efimova I.A., Sivakova O.V.; Krasnodar: Alekseenko S.N., Gubarev S.V.; Оmsk: Livzan M.A., Grishechkina I.A., Rozhkova M.Yu.; Republic of Karelia: Vezikova N.N., Skopec I. S.; Ryazan: Filippov E.V., Dobr...

Full description

Bibliographic Details
Main Authors: Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2019-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:https://www.rpcardio.com/jour/article/view/1996
id doaj-282f8d6e8c21499890afe847837fa13a
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yu. A. Balanova
S. A. Shalnova
A. E. Imaeva
А. V. Kapustina
G. A. Muromtseva
S. V. Evstifeeva
V. I. Tarasov
A. N. Redko
I. A. Viktorova
N. N. Prishchepa
S. S. Yakushin
S. A. Boytsov
O. M. Drapkina
spellingShingle Yu. A. Balanova
S. A. Shalnova
A. E. Imaeva
А. V. Kapustina
G. A. Muromtseva
S. V. Evstifeeva
V. I. Tarasov
A. N. Redko
I. A. Viktorova
N. N. Prishchepa
S. S. Yakushin
S. A. Boytsov
O. M. Drapkina
Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
Racionalʹnaâ Farmakoterapiâ v Kardiologii
hypertension
awareness
antihypertensive therapy
control of the hypertension
author_facet Yu. A. Balanova
S. A. Shalnova
A. E. Imaeva
А. V. Kapustina
G. A. Muromtseva
S. V. Evstifeeva
V. I. Tarasov
A. N. Redko
I. A. Viktorova
N. N. Prishchepa
S. S. Yakushin
S. A. Boytsov
O. M. Drapkina
author_sort Yu. A. Balanova
title Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
title_short Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
title_full Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
title_fullStr Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
title_full_unstemmed Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
title_sort prevalence, awareness, treatment and control of hypertension in russian federation (data of observational esserf-2 study)
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2019-09-01
description Participants of the study ESSE-RF-2 and co-authors: Moscow: Konstantinov V. V., Pokrovskaya M.S., Efimova I.A., Sivakova O.V.; Krasnodar: Alekseenko S.N., Gubarev S.V.; Оmsk: Livzan M.A., Grishechkina I.A., Rozhkova M.Yu.; Republic of Karelia: Vezikova N.N., Skopec I. S.; Ryazan: Filippov E.V., Dobrynina N.V., Nikulina N.N., Pereverzeva K.G., Moseychuk K.A.Aim. Evaluate the prevalence, awareness, treatment, and control of hypertension among people aged 25-64 examined in 4 regions of the Russian Federation. Material and methods. Study materials were the representative selections of non-organized male (n=3000) and female (n=3714) inhabitants of aged 25-64 from 4 regions of the Russian Federation (Krasnodar region, Omsk region, Ryazan region, the Republic of Karelia), response rate>80%. Systematic stratified multilevel random election was formed with locality criteria (Kisch method). All the participants were interviewed using the standard questionnaire. The universal epidemiological methods and evaluation criteria were used. The study was approved by the local ethics Committee of National research center for preventive medicine. Participants signed informed consent. Hypertension was defined as an average systolic blood pressure (SBP)≥140 mmHg and/or average diastolic blood pressure (DBP)≥90 mmHg and/or antihypertensive therapy (AHT). The efficacy of treatment was the achievement of the target BP. Control group – patients with BP<140/90 mmHg. Results. Mean SBP and DBP were 128.7±0,3 mmHg and 82.8±0.1 mmHg, respectively, higher BP was detected among male (p<0,001). The prevalence of hypertension was 44.2% that was higher among males than females (49.1% vs 39.9%, р˂0.0005), the highest hypertension frequency was in the Ryazan region. The awareness of hypertension was higher among females than in males 76.8% vs 69.4%. There were more persons with hypertension grade 1 among those, who were not aware of the hypertension. Medications were taken by 65.5% of females and 41.8% of males.Angiotensin-converting enzyme inhibitors were received by 49.9% of patients, angiotensin II receptor antagonists by 30.9%, beta blockers – 29.5%, diuretics – 22.7%, calcium antagonists – 15.7%, centrally acting drugs – 3.3%, others – 0.2%. The lack of AHT intake was negatively associated with age, ischemic heart disease, urban life and hypo-HDL especially among males. Heart rate >80 per min in females increased by 1.7 times the probability of absence of AHT. The prevalence of effectively treated was 49.7% of the participants with hypertension. The associations between ineffective treatment and abdominal obesity, ischemic heart disease (males), age, rural type of settlement, obesity (females) were found. Only 24.9% of patients had control of the hypertension.Conclusion. The prevalence of hypertension in Russian Federation remains high. An important task of the medical community is to identify the disease at an earlier stage of its development, before the appearance of complications. This approach can reduce the period from the onset of high blood pressure to a visit to the doctor.
topic hypertension
awareness
antihypertensive therapy
control of the hypertension
url https://www.rpcardio.com/jour/article/view/1996
work_keys_str_mv AT yuabalanova prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT sashalnova prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT aeimaeva prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT avkapustina prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT gamuromtseva prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT svevstifeeva prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT vitarasov prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT anredko prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT iaviktorova prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT nnprishchepa prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT ssyakushin prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT saboytsov prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
AT omdrapkina prevalenceawarenesstreatmentandcontrolofhypertensioninrussianfederationdataofobservationalesserf2study
_version_ 1717816480702136320
spelling doaj-282f8d6e8c21499890afe847837fa13a2021-09-03T13:15:30ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532019-09-0115445046610.20996/1819-6446-2019-15-4-450-4661629Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)Yu. A. Balanova0S. A. Shalnova1A. E. Imaeva2А. V. Kapustina3G. A. Muromtseva4S. V. Evstifeeva5V. I. Tarasov6A. N. Redko7I. A. Viktorova8N. N. Prishchepa9S. S. Yakushin10S. A. Boytsov11O. M. Drapkina12National Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineKuban State Medical UniversityOmsk State Medical UniversityCenter for Medical Prevention of the Republic of KareliaRyazan State Medical University named after Academician I.P. PavlovNational Medical Research Center of CardiologyNational Medical Research Center for Preventive MedicineParticipants of the study ESSE-RF-2 and co-authors: Moscow: Konstantinov V. V., Pokrovskaya M.S., Efimova I.A., Sivakova O.V.; Krasnodar: Alekseenko S.N., Gubarev S.V.; Оmsk: Livzan M.A., Grishechkina I.A., Rozhkova M.Yu.; Republic of Karelia: Vezikova N.N., Skopec I. S.; Ryazan: Filippov E.V., Dobrynina N.V., Nikulina N.N., Pereverzeva K.G., Moseychuk K.A.Aim. Evaluate the prevalence, awareness, treatment, and control of hypertension among people aged 25-64 examined in 4 regions of the Russian Federation. Material and methods. Study materials were the representative selections of non-organized male (n=3000) and female (n=3714) inhabitants of aged 25-64 from 4 regions of the Russian Federation (Krasnodar region, Omsk region, Ryazan region, the Republic of Karelia), response rate>80%. Systematic stratified multilevel random election was formed with locality criteria (Kisch method). All the participants were interviewed using the standard questionnaire. The universal epidemiological methods and evaluation criteria were used. The study was approved by the local ethics Committee of National research center for preventive medicine. Participants signed informed consent. Hypertension was defined as an average systolic blood pressure (SBP)≥140 mmHg and/or average diastolic blood pressure (DBP)≥90 mmHg and/or antihypertensive therapy (AHT). The efficacy of treatment was the achievement of the target BP. Control group – patients with BP<140/90 mmHg. Results. Mean SBP and DBP were 128.7±0,3 mmHg and 82.8±0.1 mmHg, respectively, higher BP was detected among male (p<0,001). The prevalence of hypertension was 44.2% that was higher among males than females (49.1% vs 39.9%, р˂0.0005), the highest hypertension frequency was in the Ryazan region. The awareness of hypertension was higher among females than in males 76.8% vs 69.4%. There were more persons with hypertension grade 1 among those, who were not aware of the hypertension. Medications were taken by 65.5% of females and 41.8% of males.Angiotensin-converting enzyme inhibitors were received by 49.9% of patients, angiotensin II receptor antagonists by 30.9%, beta blockers – 29.5%, diuretics – 22.7%, calcium antagonists – 15.7%, centrally acting drugs – 3.3%, others – 0.2%. The lack of AHT intake was negatively associated with age, ischemic heart disease, urban life and hypo-HDL especially among males. Heart rate >80 per min in females increased by 1.7 times the probability of absence of AHT. The prevalence of effectively treated was 49.7% of the participants with hypertension. The associations between ineffective treatment and abdominal obesity, ischemic heart disease (males), age, rural type of settlement, obesity (females) were found. Only 24.9% of patients had control of the hypertension.Conclusion. The prevalence of hypertension in Russian Federation remains high. An important task of the medical community is to identify the disease at an earlier stage of its development, before the appearance of complications. This approach can reduce the period from the onset of high blood pressure to a visit to the doctor.https://www.rpcardio.com/jour/article/view/1996hypertensionawarenessantihypertensive therapycontrol of the hypertension